
Simulating clinical trials before patients enroll
Pharma is moving from AI-driven drug discovery to AI-driven trial simulation to fix a costly ninety percent failure rate.
Discover the newest research about AI innovations in Research.

Pharma is moving from AI-driven drug discovery to AI-driven trial simulation to fix a costly ninety percent failure rate.

A rigorous new evaluation reveals that wrist-worn wearables capture no real blood glucose data, exposing a major flaw in non-invasive tracking claims.

As federal regulators struggle to keep pace with the clinical AI boom, private oversight is stepping in to draw the guardrails.

A new AI model predicts kidney cancer survival better than the gold-standard human grading system.

Deploying diagnostic AI to vulnerable populations is a high-stakes test of whether technology can solve the physician shortage without worsening health disparities.

Pairing untrained staff with artificial intelligence could solve the specialist shortage in operating rooms.

A young startup is spending hundreds of millions to prove that artificial intelligence can salvage stalled drug pipelines.

A new foundation model proves that simple heart and breathing signals recorded during sleep can predict complex brain and heart diseases.

Federal regulators are closing the fast track to extra Medicare funding, forcing medical device makers to prove real clinical value rather than relying on a prestigious FDA label.

Giving consumer smart ring data to a raw language model to spot depression fails completely, unless you teach it how to think first.